RT Plus ADT Tops Brachytherapy Boost for Prostate Cancer

]]>(MedPage Today) -- Men with localized prostate cancer lived longer when treated with external beam radiation therapy (EBRT) plus androgen deprivation therapy (ADT) but not EBRT with a brachytherapy boost (BT), a meta-analysis showed.The addition...